RBC Capital Markets Boosts Diaceutics PT, Keeps at Outperform

MT Newswires · 1d ago
08:41 AM EST, 11/13/2026 (MT Newswires) -- RBC Capital Markets on Friday raised the price target for pharmaceutical and biotech technology provider Diaceutics (DXRX.L) to 2.40 pounds sterling from 1.85 pounds and affirmed its outperform rating. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)